Comparison of progression-free survival (PFS) with best or confirmed response (BR, CR) as an endpoint for overall survival (OS) in advanced non small cell lung cancer (A-NSCLC): A North Central Cancer Treatment Group (NCCTG) investigation
- Citation:
- J Clin Oncol vol 26 (15s) abstr 8021
- Meeting Instance:
- ASCO 2008
- Year:
- 2008
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- NCTN
- Endpoint:
- Secondary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- Yes
- Parents:
- None
- Children:
- 278
- Program:
- OGC
- Primary Committee:
- Respiratory
- Sec. Committees:
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- S. J. Mandrekar S. L. Hillman K. L. Allen Ziegler N. F. Reuter K. M. Rowland Jr R. S. Marks S. E. Schild A. A. Adjei
- Networks:
- Study
- NCCTG-N0424
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- Keywords: